Soji Kakiuchi

Tokushima, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Tepotinib-induced interstitial lung disease in a patient with adenosquamous lung carcinoma.

Tepotinib-induced interstitial lung disease in a patient with adenosquamous lung carcinoma.

Journal: Respiratory medicine case reports

Published: June 20, 2025

Granulocyte colony-stimulating factor has the potential to attenuate the therapeutic efficacy of chemo-immunotherapy for extensive-stage small-cell lung cancer.

Granulocyte colony-stimulating factor has the potential to attenuate the therapeutic efficacy of chemo-immunotherapy for extensive-stage small-cell lung cancer.

Journal: International journal of clinical oncology

Published: June 06, 2024

A Case of Autoimmune Pulmonary Alveolar Proteinosis With Predominantly Peripheral Opacities Diagnosed by Transbronchial Lung Biopsy.

A Case of Autoimmune Pulmonary Alveolar Proteinosis With Predominantly Peripheral Opacities Diagnosed by Transbronchial Lung Biopsy.

Journal: Cureus

Published: February 15, 2024

Two Cases of Mycobacterium shinjukuense Pulmonary Disease With a Long-Term Response to Treatment With Clarithromycin, Rifampicin, and Ethambutol.

Two Cases of Mycobacterium shinjukuense Pulmonary Disease With a Long-Term Response to Treatment With Clarithromycin, Rifampicin, and Ethambutol.

Journal: Cureus

Published: January 24, 2024

Study on the Optimal Dose of Irinotecan for Patients with Heterozygous Uridine Diphosphate-Glucuronosyltransferase 1A1 (UGT1A1).

Study on the Optimal Dose of Irinotecan for Patients with Heterozygous Uridine Diphosphate-Glucuronosyltransferase 1A1 (UGT1A1).

Journal: Biological & pharmaceutical bulletin

Published: November 06, 2019

The clinical features of older patients with lung cancer in comparison with their younger counterparts.

The clinical features of older patients with lung cancer in comparison with their younger counterparts.

Journal: Respiratory investigation

Published: June 23, 2018

A multicenter, open-label, phase II trial of S-1 plus carboplatin in advanced non-small cell lung cancer patients with interstitial lung disease.

A multicenter, open-label, phase II trial of S-1 plus carboplatin in advanced non-small cell lung cancer patients with interstitial lung disease.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: May 07, 2018

Phase II study of tailored S-1 monotherapy with a 1-week interval after a 2-week dosing period in elderly patients with advanced non-small cell lung cancer.

Phase II study of tailored S-1 monotherapy with a 1-week interval after a 2-week dosing period in elderly patients with advanced non-small cell lung cancer.

Journal: Respiratory investigation

Published: June 02, 2017

Analysis of the Prognostic Factors of Extensive Disease Small-Cell Lung Cancer Patients in Tokushima University Hospital.

Analysis of the Prognostic Factors of Extensive Disease Small-Cell Lung Cancer Patients in Tokushima University Hospital.

Journal: The journal of medical investigation : JMI

Published: September 21, 2016

Pemetrexed-Induced Rash May Be Prevented by Supplementary Corticosteroids.

Pemetrexed-Induced Rash May Be Prevented by Supplementary Corticosteroids.

Journal: Biological & pharmaceutical bulletin

Published: November 03, 2015

Analysis of acute exacerbation of interstitial lung disease associated with chemotherapy in patients with lung cancer: A feasibility of S-1.

Analysis of acute exacerbation of interstitial lung disease associated with chemotherapy in patients with lung cancer: A feasibility of S-1.

Journal: Respiratory investigation

Published: October 22, 2015

Characteristics of and risk factors for interstitial lung disease induced by chemotherapy for lung cancer.

Characteristics of and risk factors for interstitial lung disease induced by chemotherapy for lung cancer.

Journal: The Annals of pharmacotherapy

Published: January 08, 2015

Showing 1-12 of 21

Last Updated: 09/26/2026